T. Rowe Price Group, Inc. reported its results for the third quarter of 2026, revealing a challenging period marked by significant client outflows and a decline in assets under management. The firm, known for its investment advice services, reported net client outflows of $28.3 billion, which contributed to a total of $1.9 trillion in assets under management (AUM).
Rob Sharps, chair and CEO, emphasized the company’s commitment to innovation, stating, “We continue to expand our ETF, SMA, and model portfolio businesses, extending our active investment expertise to more clients through a broader range of portfolio solutions.” Despite the outflows, T. Rowe Price remains focused on enhancing its product offerings and improving investment performance.
Background
T. Rowe Price Group, Inc., incorporated in Maryland, operates in the investment advice sector (SIC: 6282). The firm trades on the Nasdaq under the ticker symbol TROW. It is classified as a large accelerated filer and has a fiscal year ending on December 31. Recent filings include an 8-K on October 29, 2026, and multiple Form 4s throughout September and October 2026.
What the Filing Says
In the recent 8-K filing, T. Rowe Price disclosed its earnings release for the three and nine months ending September 30, 2026. The report highlighted the firm’s financial condition, stating, “On October 29, 2026 we issued an earnings release reporting our results of operations for the three and nine months ended September 30, 2026.”
Impact
The results may affect various stakeholders, including investors, clients, and competitors in the investment advice sector. The reported net outflows and decline in assets could raise concerns among investors about the firm's market position and ability to attract new clients. Competitors in the investment advice space may also need to reassess their strategies in light of T. Rowe Price's performance.
What's Next
The filing does not say what happens next.
Read Next
ProPetro Holding reports Q3 results, highlights operational trends
Saia Inc. announces Q3 results and stock buyback program
Valion Bio Reports Positive Safety Results for Entolimod Study
BCB Bancorp restructures executive team amid Q3 losses
CRH Public Ltd Co Reports Q3 Results, Highlights Financials
CRH Public Ltd Co reports Q3 2026 financial results






